|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date14 Nov 1960 |
|
|
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Japan |
First Approval Date24 Jun 2024 |
100 Clinical Results associated with Global Regulatory Partners, Inc.
0 Patents (Medical) associated with Global Regulatory Partners, Inc.
100 Deals associated with Global Regulatory Partners, Inc.
100 Translational Medicine associated with Global Regulatory Partners, Inc.